Table 2.
Study | Sample Sizea | PS only | PS + Clin. variables | ||||
---|---|---|---|---|---|---|---|
P-val | HR | C-index | P-val | HR | C-index | ||
TCGA | 289 | 6.6E-12 | 0.92 | 0.66 | 1.5E-8 | 0.93 | 0.68 |
GSE9891 | 278 | 4.2E-9 | 0.97 | 0.7 | 4.6E-8 | 0.97 | 0.74 |
GSE32063 | 260 | 2.1E-3 | 0.88 | 0.6 | 0.01 | 0.9 | 0.64 |
GSE26712 | 185 | 1.1E-3 | 0.98 | 0.61 | 0.03 | 0.99 | 0.66 |
E.MTAB.386 | 129 | 2.3E-3 | 0.97 | 0.6 | 2.5E-3 | 0.96 | 0.63 |
PMID17290060 | 117 | 4.7E-4 | 0.97 | 0.66 | 7.4E-4 | 0.97 | 0.67 |
GSE17260 | 110 | 0.05 | 0.99 | 0.6 | 0.09 | 0.99 | 0.66 |
Sample size indicates number of gene expression samples used in analysis. PS = prognostic score. HR = hazard ratio. C-index = concordance index. Clin. variables include all clinical variables (stage, grade, age and/or debulking) available for each dataset (See Supp. Table 5).